sodium arsenite has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthumani, M; Prabu, SM | 1 |
| Abam, EO; Ademuyiwa, O; Afolabi, OK; Babayemi, DO; Balogun, EA; Dosumu, OA; Odukoya, OO; Ogunrinola, OO; Onunkwor, OB; Wusu, AD | 1 |
2 other study(ies) available for sodium arsenite and Dyslipidemia
| Article | Year |
|---|---|
Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Arsenites; Disease Models, Animal; Dyslipidemias; Heart Diseases; Heme Oxygenase (Decyclizing); Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lipids; Mitochondria, Heart; Myocardium; NADPH Oxidases; NF-E2-Related Factor 2; Oxidative Stress; Rats; Silybin; Silymarin; Sodium Compounds | 2014 |
Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Topics: Animals; Arsenates; Arsenites; Brain; Dose-Response Relationship, Drug; Drinking Water; Dyslipidemias; Erythrocytes; Hydroxymethylglutaryl CoA Reductases; Lipids; Lipoproteins; Liver; Male; Rats; Sodium Compounds | 2015 |